Chemokine pattern in relation to disease state in human immunodeficiency virus-infected children

AIDS Research and Human Retroviruses

Volumn 15, Issue 14, 1999, Pages 1279-1285

  Than, Soe ^a,b   Tumaliuan, Janet Ang ^a   Tamma, Seetha ^a   Morales, Maripaz ^a   Bakshi, Saroj ^a   Pahwa, Savita ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA CHEMOKINE; MESSENGER RNA; MONOCLONAL ANTIBODY CD3; RANTES;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSOR CELL; VIRUS LOAD;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTES; MALE; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VIRAL LOAD;

EID: 0032866515     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310179     Document Type: Article

References (18)

1. Pantaleo G and Fauci AS: New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 1995;13:487-512.
2. Harrer T, Harrer E, Kalams AS, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, and Walker BD: Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J Immunol 1996;156:2616-2623.
3. Levy JA, Mackewicz CE, and Barker E: Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ cells. Immunol Today 1996;17:217-225.
4. Cocchi F, DeVico AL, Demo GA, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
5. Pal R, Garzino-Demo A, Markham PD, Burns J, Brown M, Gallo RC, and DeVico AL: Inhibition of HIV-1 infection by the β-chemokine MDC. Science 1997;278:695-698.
6. Zhou P, Goldstein S, Devadas K, et al.: Human CD4 cells transfected with IL-16 cDNA are resistant to HIV infection: Inhibition of mRNA expression. Nature Med 1997;3:659-664.
7. Moore J and Trkola A: HIV type 1 coreceptors, neutralization serotypes, and vaccine development. AIDS Res Hum Retroviruses 1997;13:733-736.
8. McKenzie SW, Dallalio G, North M, Frame P, and Means RT Jr: Serum chemokine levels in patients with non-progressing HIV infection. AIDS 1996;10:F29-33.
9. Zanussi S, D'Andrea M, Simonelli C, Tirelli U, and De Paoli P: Serum levels of RANTES and MIP-1α and HIV-positive longterm survivors and progressors patients. AIDS 1996;10: 1431-1450.
10. Schrum S, Probst P, Fleischer B, and Zipfel P: Synthesis of the CC-chemokines MIP-1α, MIP-1β and RANTES is associated with a type 1 immune response. J Immunol 1996;157:3598-3604.
11. Clerici M and Shearer GM: The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 1994;15:575-581.
12. CDC: Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994;43(RR-12):1-10.
13. Than S, Hu R, Oyaizu N, Romano J, Wang X-P, Sheikh S, and Pahwa S: Cytokine pattern in relation to disease progression in HIV-infected children. J Infect Dis 1997;175:47-56.
14. Poli G, Alfano M, and Ghezzi S: Suppressive and enchancing effects of β-chemokine on HIV replication in in vivo infected cells. In: 4th Conference on Retroviruses and Opportunistic Infections, 1997.
15. Aukrust P, Muller F, and Froland SS: Circulating levels of RANTES in human immunodeficiency virus type 1 infection: Effect of potent antiretrovial therapy. J Infect Dis 1998;177: 1091-1096.
16. Clerici M, Balotta C, Trabattoni D, Papgno L, Ruzzante S, Rusconi S, Fusi ML, Colombo MC, and Galli M: Chemokine production in HIV-seropositive long-term asymptomatic individuals. AIDS 1996;10:1432-1433.
17. Schwartz DH, Castillo RC, Arango-Jarmillo S, Sharma U, Song H, and Sridharan G: Chemokine-independent in vitro resistance to human immunodeficiency virus (HIV-1) correlating with low viremia in long-term and recently infected HIV-1-positive persons. J Infect Dis 1997;176:1168-1174.
18. Saha K, Bentsman G, Chess L, and Volsky D: Endogenous production of β-chemokines by CD+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 1998;72:876-881.